Unknown

Dataset Information

0

The anti-inflammatory and immunomodulatory potential of braylin: Pharmacological properties and mechanisms by in silico, in vitro and in vivo approaches.


ABSTRACT: Braylin belongs to the group of natural coumarins, a group of compounds with a wide range of pharmacological properties. Here we characterized the pharmacological properties of braylin in vitro, in silico and in vivo in models of inflammatory/immune responses. In in vitro assays, braylin exhibited concentration-dependent suppressive activity on activated macrophages. Braylin (10-40 ?M) reduced the production of nitrite, IL-1?, TNF-? and IL-6 by J774 cells or peritoneal exudate macrophages stimulated with LPS and IFN-?. Molecular docking calculations suggested that braylin present an interaction pose to act as a glucocorticoid receptor ligand. Corroborating this idea, the inhibitory effect of braylin on macrophages was prevented by RU486, a glucocorticoid receptor antagonist. Furthermore, treatment with braylin strongly reduced the NF-?B-dependent transcriptional activity on RAW 264.7 cells. Using the complete Freund's adjuvant (CFA)-induced paw inflammation model in mice, the pharmacological properties of braylin were demonstrated in vivo. Braylin (12.5-100 mg/kg) produced dose-related antinociceptive and antiedematogenic effects on CFA model. Braylin did not produce antinociception on the tail flick and hot plate tests in mice, suggesting that braylin-induced antinociception is not a centrally-mediated action. Braylin exhibited immunomodulatory properties on the CFA model, inhibiting the production of pro-inflammatory cytokines IL-1?, TNF-? and IL-6, while increased the anti-inflammatory cytokine TGF-?. Our results show, for the first time, anti-inflammatory, antinociceptive and immunomodulatory effects of braylin, which possibly act through the glucocorticoid receptor activation and by inhibition of the transcriptional activity of NF-?B. Because braylin is a phosphodiesterase-4 inhibitor, this coumarin could represent an ideal prototype of glucocorticoid receptor ligand, able to induce synergic immunomodulatory effects.

SUBMITTER: Espirito-Santo RF 

PROVIDER: S-EPMC5464642 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications


Braylin belongs to the group of natural coumarins, a group of compounds with a wide range of pharmacological properties. Here we characterized the pharmacological properties of braylin in vitro, in silico and in vivo in models of inflammatory/immune responses. In in vitro assays, braylin exhibited concentration-dependent suppressive activity on activated macrophages. Braylin (10-40 μM) reduced the production of nitrite, IL-1β, TNF-α and IL-6 by J774 cells or peritoneal exudate macrophages stimul  ...[more]

Similar Datasets

| S-EPMC7463710 | biostudies-literature
| S-EPMC9322149 | biostudies-literature
| S-EPMC8391193 | biostudies-literature
| S-EPMC10573055 | biostudies-literature
| S-EPMC7953762 | biostudies-literature
| S-EPMC3773761 | biostudies-literature
| S-EPMC8708807 | biostudies-literature
| S-EPMC8400542 | biostudies-literature
| S-EPMC5108493 | biostudies-literature
| S-EPMC8143105 | biostudies-literature